Biotechnology

As genome editing moves from the lab into the clinic, the ethical debate can no longer be hypothetical

The technique should not increase social injustice or division, say bioethicists. Image: REUTERS/National Human Genome Research Institute

Karen Yeung

Chair, Nuffield Council on Bioethics Working Party

Peter Mills

Assistant Director, Nuffield Council on Bioethics

Share:

The Big Picture
Explore and monitor how Biotechnology is affecting economies, industries and global issues
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale

Stay up to date:

Biotechnology

Have you read?

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:

BiotechnologyHealth and Healthcare

Share:

Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

New research uncovers how cancer cells can become mortal, opening avenues for treatment

Pattra Chun-On and Jonathan Alder

November 23, 2022

1:29
About Us
Events
Media
Partners & Members
Language Editions

Privacy Policy & Terms of Service

© 2022 World Economic Forum